Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers; a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable device to deliver inhaled nitric oxide gas. The company was incorporated in 2011 and is based in Port Jefferson, New York.
Metrics to compare | NUMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNUMDPeersSector | |
---|---|---|---|---|
P/E Ratio | −62.9x | −3.1x | −0.5x | |
PEG Ratio | −1.39 | −0.24 | 0.00 | |
Price/Book | −17.8x | 3.2x | 2.6x | |
Price / LTM Sales | - | 5.8x | 3.2x | |
Upside (Analyst Target) | - | 12.8% | 41.9% | |
Fair Value Upside | Unlock | −0.5% | 4.3% | Unlock |